CIK 0001762303 · Non-accelerated filer<br>Smaller reporting company
AVITA Medical, Inc.
Sign in to watch- Tickers
- RCEL AVHHL
- Exchange
- Nasdaq, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202578762
- Phone
- 661-568-1317
- Business address
- 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
- Former names
- Avita Therapeutics, Inc., Avita Medical, Ltd.
Securities
- RCEL Common Stock Nasdaq
- AVHHL Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-06 | Tarnoff Michael E Director | Grant or award · Stock Options (Right to Buy) | +19,063 | 19,063 | ||
| 2025-05-30 | O'Toole David D CFO | Grant or award | +1,923 | $4.78 | $9K | 27,657 |
| 2025-03-06 | McNamara Robert Director | Purchase | +11,000 | $8.30 | $91K | 56,749 |
| 2025-02-20 | McNamara Robert Director | Purchase | +10,000 | $10.09 | $101K | 45,749 |
| 2025-02-20 | O'Toole David D CFO | Purchase | +1,000 | $9.90 | $10K | 25,734 |
| 2025-02-19 | O'Toole David D CFO | Purchase | +1,000 | $10.25 | $10K | 24,734 |
| 2025-01-21 | Vance Cary Guy Director | Grant or award | +10,022 | 35,771 | ||
| 2025-01-21 | Vance Cary Guy Director | Grant or award · Stock Options (Right to Buy) | +4,295 | 4,295 | ||
| 2025-01-21 | REED JAN STERN Director | Grant or award | +10,022 | 51,011 | ||
| 2025-01-21 | REED JAN STERN Director | Grant or award · Stock Options (Right to Buy) | +4,295 | 4,295 | ||
| 2025-01-21 | McNamara Robert Director | Grant or award | +10,022 | 66,771 | ||
| 2025-01-21 | McNamara Robert Director | Grant or award · Stock Options (Right to Buy) | +4,295 | 4,295 | ||
| 2025-01-21 | COOK JEREMY CURNOCK Director | Grant or award | +10,022 | 39,836 | ||
| 2025-01-21 | COOK JEREMY CURNOCK Director | Grant or award · Stock Options (Right to Buy) | +4,295 | 4,295 | ||
| 2025-01-21 | Crowe Suzanne Director | Grant or award | +10,022 | 46,934 | ||
| 2025-01-21 | Crowe Suzanne Director | Grant or award · Stock Options (Right to Buy) | +4,295 | 4,295 | ||
| 2025-01-21 | Panaccio Lou Director | Grant or award | +10,022 | 56,428 | ||
| 2025-01-21 | Panaccio Lou Director | Grant or award · Stock Options (Right to Buy) | +4,295 | 4,295 | ||
| 2025-01-21 | CORBETT JAMES CEO | Grant or award · Stock Options (Right to Buy) | +520,000 | 520,000 | ||
| 2025-01-21 | O'Toole David D CFO | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 |
Page 3 of 10 · 185 trades